Previous Article | Next Article 
Molecular and Cellular Biology, May 2000, p. 3266-3273, Vol. 20, No. 9
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Identification of a Series of Transforming Growth
Factor
-Responsive Genes by Retrovirus-Mediated Gene
Trap Screening
Nobutake
Akiyama,1
Yoshiyuki
Matsuo,1
Heitetsu
Sai,2
Makoto
Noda,1,* and
Shinae
Kizaka-Kondoh1
Department of Molecular
Oncology1 and Department of
Radiology,2 Kyoto University Graduate School
of Medicine, Sakyo-ku, Kyoto 606-8501, Japan
Received 13 September 1999/Returned for modification 19 October
1999/Accepted 19 January 2000
 |
ABSTRACT |
Transforming growth factor
(TGF-
) plays important roles in
the regulation of proliferation, differentiation, apoptosis, and
carcinogenesis. To identify genes responsible for maintaining the
phenotype induced by TGF-
, we performed a retrovirus-mediated gene
trap screening designed to isolate TGF-
-responsive genes in human
lung carcinoma cell line A549. After screening 249 trap lines, 21 were
found to express the reporter
-galactosidase gene in a
TGF-
-responsive manner. Interestingly, in large proportions of these
trap lines, the reporter gene was responsive also to phorbol ester and
was suppressed by gamma interferon. Fragments of all these trapped
genes were recovered by 5'- and 3'-rapid amplification of cDNA ends
(RACE), and in 15 out of 21 cases (71%), the TGF-
responsiveness of
the endogenous genes was confirmed by RNA blot hybridization. In at
least five cases, the TGF-
-induced upregulation was found to be
cycloheximide resistant, suggesting the roles of the genes in the
TGF-
-induced primary responses. Sequence analyses revealed that 43%
(9 of 21) of the trapped genes were novel and that the remainder
included genes previously reported to be upregulated by TGF-
, such
as epidermal growth factor receptor and
1 integrin, documenting the
validity of this approach. Other known genes include the ones encoding
the proteins associated with cell proliferation (ribosomal proteins
S15a, hNRP/NAP-1, and lipocortin II), focal adhesions (paxillin), and
transcriptional regulation (thyroid hormone receptor activator molecule
1 [TRAM-1]).
 |
INTRODUCTION |
Transforming growth factor
(TGF-
) represents a large family of secreted polypeptides playing
important roles in the regulation of various cellular responses
(34). The prototype member, TGF-
1, is of particular
importance in cancer research, since it inhibits the growth of certain
types of cells in vitro (32, 38), and since mutational
inactivation of its signaling molecules is found in human tumors
(17, 34). Recent studies have revealed the nature of a
TGF-
signaling pathway where SMAD family proteins play central roles
in transmitting a signal from the receptor serine/threonine kinase at
the cell surface directly to the nuclear transcription machinery
(21, 34, 52). The TGF-
signal induces the expression of
several inhibitors for cyclin-dependent kinases, such as
p21Cip1, p15Ink4B, and p27Kip1,
which have previously been proposed as mediators for TGF-
-induced growth inhibition (7, 18, 37). It is therefore likely that other important factors for TGF-
functions can also be found among
the genes transcriptionally regulated by the TGF-
signal.
The study of differentially expressed genes has been one of the most
promising approaches to identifying genes important for growth,
differentiation, and development. Recent technical advances and
improvements are accelerating the analysis of gene expression profiles
at the transcript level. These methods include suppression subtractive
hybridization (9), differential display (23, 30),
comparative expressed sequence tag analysis (29, 50), serial
analysis of gene expression (51), and DNA microarrays (42). One drawback to these methods, however, is that since they use mRNA as a starting material, they tend to preferentially detect abundantly expressed genes.
In this study, we have employed a supplementary approach to screen and
identify genes responsive to various external stimuli in cultured
cells. Our method is based on a "gene trap" initially designed for
random insertional mutagenesis in mouse embryonic stem cells and uses a
retroviral vector to introduce a promoterless reporter gene into the
host chromosomes (12, 13, 16). Retroviral DNA is known to
integrate into numerous sites in the host chromosomes with no obvious
sequence specificity, although transcriptionally active regions may be
preferred targets for integration (43). The reporter gene of
this vector can only be expressed if it inserts within an intron, an
exon, or a promoter of a transcriptionally active gene in the right
orientation. This allows one to select for the cells (trap line) in
which the insertion has occurred and to obtain the sequences of the
trapped genes useful for gene identification as well as subsequent
cloning. Furthermore, the responses of the trapped genes to various
factors can be readily examined by staining the trap lines with X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) after
exposure to these factors. Such examination may provide important
information not only on the behavior of the trapped genes themselves
but also on the interactions between the signals evoked by these factors.
Several groups have previously used the gene trap to identify genes
whose expression was either induced or suppressed during cellular
differentiation (11, 26), oncogenic transformation (2), and apoptosis (39). By modifying the
reporter/selection marker system, we adapted this method so as to be
suitable for rapid screening of differentially expressed genes in
cultured cells. Our initial attempt to apply this method to the
screening of genes upregulated by TGF-
led to the identification of
a series of interesting genes, including several novel genes, and has
demonstrated the feasibility and efficacy of this approach.
 |
MATERIALS AND METHODS |
Cell culture.
The A549 human lung adenocarcinoma cell line
(15) (obtained from the American Type Culture Collection)
was maintained in Dulbecco modified Eagle medium supplemented with 5%
fetal calf serum, penicillin (100 U/ml), and streptomycin (100 µg/ml)
(growth medium [GM]). Additional medium factors and their
concentrations were as follows: 5 ng of recombinant human epidermal
growth factor (EGF; Toyobo)/ml, 5 ng of recombinant human
platelet-derived growth factor (PDGF) AB heterodimer (R & D
Systems)/ml, 5 ng of recombinant human insulin-like growth factor
(IGF-1; Roche Diagnostics)/ml, 1 to 2.5 ng of recombinant human
transforming growth factor
1 (TGF-
1; R & D Systems)/ml, 200 IU of
recombinant human gamma interferon (IFN-
); Roche Diagnostics)/ml, 10 µM T3 (Sigma), 10 ng of phorbol 12-myristate 13-acetate (PMA;
Sigma)/ml, and 0.1 mM
6N,2'-O-dibutyryladenosine
3':5'-cyclic monophosphate (dbcAMP; Sigma).
Vector construction and virus preparation.
pROSA-nGBT
plasmid was constructed by modifying pROSA
-geo (12).
First, the 5' HindIII-BamHI fragment
corresponding to the
-galactosidase (
-Gal) portion of
-geo was
replaced with the nuclear localization signal (NLS) of simian virus 40 large T antigen (3) using synthetic oligonucleotides.
Second, the BamHI-XbaI fragment corresponding to
the neo coding sequences of
-geo was replaced with a
herpes simplex virus (HSV) thymidine kinase (TK) gene fragment
(1). Third, a DNA fragment encoding blasticidin-S (BLA-S)
deaminase (24) was amplified by PCR using pUCSV-BSD plasmid
(Kaken) as a template and inserted into the BamHI site located between the
-Gal and HSV TK gene sequences. The ends of each
fragment were designed so that the final construct, designated nGBT,
encoded a contiguous fusion protein. Finally, the nGBT gene was
inserted between the HindIII and XbaI sites
of the original pROSA
-geo vector, resulting in the replacement of
-geo with nGBT. pROSA-nGBT DNA was transfected into an
amphotropic packaging host (GP+envAm12) (33), and freshly
harvested culture supernatant was used as the ROSA-nGBT virus preparation.
Gene trap screening.
In the first experiment, A549 cells
(106 cells in 10 60-mm-diameter dishes) were infected with
ROSA-nGBT virus and after 48 h were treated with TGF-
1 (2.5 ng/ml) for 14 h and then with TGF-
1 plus BLA-S (8 µg/ml) for
7 days. The BLA-S-resistant colonies were trypsinized, pooled, and
plated (splitting ratio, 1:10) into new dishes with GM. After a 5-day
incubation, the cells were treated with ganciclovir (GCV) (0.2 µM;
Roche) for 5 days. In the second experiment, a total of 2.6 × 106 A549 cells (2 × 105 cells per
100-mm-diameter dish) were infected with ROSA-nGBT virus. TGF-
1 was
added 3 days later, and BLA-S (2 µg/ml) was added on the following
day. The selection medium was renewed once every 3 to 4 days. Colonies
that survived these treatments were isolated and expanded, and their
aliquots were plated in duplicate onto 24-well plates (one well without
TGF-
and the other with TGF-
). After 48 h of incubation, the
cells were stained with X-Gal (see below). Trap lines that stained
deeper in the presence of TGF-
1 than in its absence were subjected
to further analyses.
cDNA isolation.
5'-Rapid amplification of cDNA ends
(5'-RACE) and 3'-RACE were performed following the protocols of Parry
and Alphey (36) with slight modifications. Briefly, for
5'-RACE, total RNA was isolated using MagExtractor (Toyobo) from a
trap line grown to subconfluence on a 60-mm-diameter dish. The
negative-strand cDNA that contained the vector sequence was selectively
reverse transcribed from the RNA sample using Revertra-Ace (Toyobo) and
a
-Gal-specific primer (Gal-rev: 5'-CAA CCA CCG CAC GAT AGA GAT
TC-3'). The reaction products were treated with RNase H and purified
using a QiaQuick PCR purification kit (Qiagen). A deoxyribosyladenine
tail was added using terminal deoxynucleotidyl transferase, and the
reaction products were amplified by nested PCR. The first PCR (30 cycles) was performed in the presence of 10% dimethyl sulfoxide (DMSO) with the forward tail-anchored primer UNIZAP-dT (5'-GAG AGA GAG AGA GAG
AGA GAA CTA GTC TCG AGT TTT TTT TTT TTT TTT TT-3') and the NLS-based
reverse primer NLS-3S (5'-GAT CAA CCT TCC TCT TCT TCT TAG-3'). The
second PCR (30 cycles) was performed in the absence of DMSO with the
same forward primer, UNIZAP-dT, and the splice acceptor-based reverse
primer SA-REV (5'-TCG ATC CCC ACT GGA AAG ACC GCG A-3'). For 3'-RACE,
poly(A)+ RNA was isolated from total RNA of untreated A549
cells using an oligo(dT) cellulose column and reverse transcribed with
semirandom primers (WALK-A [5'-GTA ATA CGA CTC ACT ATA GGG CAC GCG TGG
NNN GTS AC-3'] or WALK-B [5'-GTA ATA CGA CTC ACT ATA GGG CAC GCG TGG NNN GAW TC-3']). The first PCR (30 cycles) was performed using a
forward primer specific to each gene (gene-specific primer 1) and
arbitrary reverse primer AP-1 (5'-GTA ATA CGA CTC ACT ATA GGG C-3').
The second PCR (30 cycles) was performed using another forward primer
corresponding to a downstream sequence of the gene (gene-specific
primer 2) and reverse primer AP-2S (5'-ACT ATA GGG CAC GCG TGG T-3').
Amplified fragments of both 3'- and 5'-RACE were subcloned into
pBluescript II SK(
) and sequenced using DyeTerminator Bigdye (ABI).
Standard protocols (40) were used for general techniques in
DNA manipulation and nucleic acid analyses.
RNA blot hybridization.
A549 cells were cultured in GM, GM
containing 2.5 ng of TGF-
/ml, or GM containing 2.5 ng of TGF-
and
10 µg of cycloheximide (CHX)/ml for 48 h, and their total RNA
was extracted by the guanidinium-cesium chloride method as described
previously (40). The RNA (20 µg) was subjected to
electrophoresis in a 1% agarose gel containing formaldehyde and
transferred to a Hybond-N (Amersham) nylon filter using 20× SSC (1×
SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The resulting filter
was hybridized with each of the following probes: 5'-RACE products for
A4 (800 bp), A21 (450 bp), A82 (100 bp), and A143 (140 bp); 3'-RACE
products for A26 (1.7 kb), A70 (1.4 kb), A161 (420 bp), A162 (370 bp),
and A164 (210 bp); reverse transcription-PCR products containing coding
regions for A80 (1.3 kb), A96 (280 bp), A89 (700 bp), A100 (1 kb), A114
(1.2 kb), A116 (1.4 kb), A126 (290 bp), A152 (1.2 kb), and A153 (340 bp); an 850-bp fragment containing the full coding region of A83; a
1.4-kb fragment containing the pyruvate kinase coding region
(35) for A14; and a 2.4-kb fragment containing the 5' coding
region of thyroid hormone receptor activator molecule 1 (TRAM-1) cDNA
(46) for A88. All the probes were labeled with
[
-32P]dCTP using Ready-To-Go DNA-labeling beads
(Amersham), followed by purification using MicroSpin columns (Amersham).
-Gal assay and X-Gal staining.
Cells
(105/well) were seeded onto six-well plates in duplicate,
and on the following day TGF-
(1 ng/ml) was added to one of a pair.
The cells were further cultured for 48 h, trypsinized, counted,
and lysed with 1× reporter lysis buffer (Promega) to yield the lysates
with the same cell concentration (106 cells/ml). The
lysates (100 µl) were subjected to the colorimetric enzyme assay in
triplicate using the
-Gal enzyme assay system (Promega). The
experiments were repeated at least three times. To examine the response
of trapped genes to various other agents (Fig. 3, Table 1), cells
(104/well) were seeded onto a 24-well-plate, and on the
following day, appropriate growth factors and/or chemicals were added.
After 48 h of incubation, the cells were fixed and treated with an
X-Gal staining solution (5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mM MgCl2, 0.04% X-Gal) at 37°C for
24 h (41). The experiments were repeated twice with
similar results.
 |
RESULTS |
Construction of gene trap vector.
To facilitate screening for
differentially expressed genes in cultured cells, we constructed a gene
trap vector carrying a newly developed reporter gene, nGBT, next to the
splice acceptor site in the self-inactivating retroviral vector
pROSA
-geo (12). The nGBT gene encodes a fusion protein
consisting of four parts: NLS,
-Gal, BLA-S deaminase, and HSV TK
(Fig. 1). When ROSA-nGBT virus infects
the cells and the vector integrates into an active transcriptional unit
of the host genome in the appropriate orientation, a chimeric
transcript containing a 5' segment of the host gene (trapped gene)
spliced into the splice acceptor sequence located at 5' end of the nGBT
reporter gene will be expressed (Fig. 1). Such cell clones (trap lines)
will become resistant to BLA-S and sensitive to GCV. The expression
profile of the trapped gene can be monitored using
-Gal activity.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Gene trap strategy with ROSA-nGBT vector. In the cells
infected with this virus, the integrated proviral DNA became
transcriptionally silent. The nGBT reporter gene lacks its own promoter
but is preceded by a strong splice acceptor sequence. When the viral
DNA is integrated in an active transcriptional unit in the host genome,
the nGBT gene can be transcribed as a part of the chimeric mRNA whose
5' portion is derived from the host transcript. SA, splice acceptor.
|
|
Isolation of gene trap cell lines responsive to TGF-
.
To
detect the genes persistently upregulated in response to TGF-
, we
infected human lung carcinoma cell line A549 with ROSA-nGBT virus and
selected the cells with BLA-S in the presence of TGF-
for a week.
TGF-
is known to suppress the anchorage-independent growth of A549
cells (38). We observed that in the presence of 1 ng of
TGF-
1/ml the rate of their anchorage-dependent growth was also
decreased to one-third that of their untreated counterparts and that
their morphology became flatter (data not shown). In the first
experiment, to eliminate the trap lines constitutively expressing a
high level of reporter gene, counter-selection with GCV in the absence
of TGF-
was performed. A total of 117 trap lines were obtained after
these selections, and the induction of the reporter expression was
examined by X-Gal staining in the presence or absence of TGF-
.
Thirteen trap lines (lines A4 to A114) were stained deeper in the
presence of TGF-
and isolated for further analysis. We found that
the majority of trap lines expressed the reporter gene at certain
levels without TGF-
treatment (Fig. 2;
see below) and that GCV damaged the cells at the concentration we used
(0.2 mM). Therefore in the second experiment, the GCV selection was
omitted, and out of 132 BLA-S-resistant clones, eight additional trap
lines (A116, A126, A143, A152, A153, A161, A162, and A164) showing
TGF-
responsiveness were isolated for further analysis. To estimate
the extent of reporter gene induction, we performed a quantitative
-Gal assay with each trap line incubated in the presence and absence
of TGF-
. The induction index (
-Gal activity for TGF-
-treated
cells divided by
-Gal activity for untreated cells) was found to
range from 1.62 to 6.34 (Fig. 2).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 2.
Quantitative analysis of the reporter gene activities in
trap lines. Each trap line was cultured in the presence (TGF- ) or
absence (None) of TGF- 1 for 48 h, and -Gal activities in the
cell lysates were determined. Each bar represents the average activity
and the standard error from triplicate cultures. The experiments were
repeated at least three times, and the data from a typical experiment
are presented. The induction index (activity of TGF- -treated cells
divided by activity of untreated cells) is shown at the bottom.
Parental A549 cells and R3, a trap line whose X-Gal staining pattern
was found to be unaffected by TGF- , were included as controls. The
P value for each pair of data (Student's t test)
was at most 2 × 10 4 (i.e., significant
difference).
|
|
Response of reporter gene in the trap lines to other agents.
Southern blot analysis indicated that each of the trap lines isolated
under these conditions contained a single copy of integrated vector DNA
(data not shown). The behavior of the reporter gene in a trap line must
therefore reflect the nature of a trapped promoter, which can be
readily monitored by X-Gal assay. Taking advantage of this readiness,
we attempted to classify these trap lines based on the spectra of their
responses to various stimuli applied alone or in conjunction with
TGF-
. An example of such experiments is shown in Fig.
3. The results with some of the trap lines (Table 1) revealed several
interesting patterns. First, a majority of the trap lines tested (11 of
14) also responded to a phorbol ester, PMA. Second, IFN-
suppressed
the TGF-
-induced reporter expression in many trap lines (12 of 14).
Third, neither induction nor suppression of the reporter gene was
detected after treatment with EGF, IGF-1, PDGF, a cyclic AMP analogue
(dbcAMP), or thyroid hormone (tri-iodo-L-thyronine; T3) in
these trap lines. A slight induction of the reporter gene was observed
in A80 when treated with dbcAMP in the presence of TGF-
.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
Response of the A116 trap line to various agents. A114
cells were incubated in medium containing the indicated growth factors
and/or chemicals for 48 h and were stained with X-Gal.
|
|
Response of endogenous genes to TGF-
in A549 cells.
Since
the
-Gal assay and X-Gal staining evaluate the expression levels of
the reporter protein in the context of the integrated proviral DNA,
they may not exactly reflect the behavior of the corresponding
endogenous genes. We therefore analyzed the response of the endogenous
mRNA to TGF-
in the parental A549 cells by RNA blot hybridization
using the cDNA fragment of each trapped gene (see Materials and
Methods) as a probe (Fig. 4). Strong
upregulation by TGF-
was detected in five cases (A4, A21, A26, A116,
and A162), and weak but significant upregulation was detected in seven
cases (A70, A96, A100, A114, A126, A152, and A161). More than one band was detected with the A100 and A114 probes, and the upper band and all
three bands, respectively, seem to be responsive to TGF-
. A slight
but reproducible upregulation was also detected with the A83 probe. On
the other hand, no clear upregulation was observed in four cases (A14,
A80, A152, and A164), and no hybridization bands were detected in two
cases (A89 and A143). Taking all the data together, upregulation by
TGF-
was confirmed by RNA blot hybridization in 15 out of 21 cases
(71%).

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 4.
Northern blot analysis of the endogenous transcripts.
Endogenous transcripts corresponding to the trapped genes were detected
by Northern blot analysis with total RNA from parental A549 cells
cultured in either GM, 2.5-ng/ml TGF- , or 2.5-ng/ml TGF- plus
10-µg/ml CHX for 48 h. Probes used are described in Materials
and Methods. For the estimation of the quality and quantity of RNA
samples, ethidium bromide-stained RNA on the blot is shown in the lower
portion of each panel.
|
|
To examine whether these genes are direct targets for TGF-

or not,
we compared the response of these genes to TGF-

in the
presence or
absence of CHX, an inhibitor of de novo protein synthesis
(Fig.
4). In
most cases (A14, A21, A26, A80, A96, A100, A116,
A153, and A161), their
transcripts further increased with CHX
treatment, and in some cases
(A70, A82, A88, A114, A162, and A164)
their transcripts decreased. The
levels of expression of the rest
(A4, A83, A126, and A152) were not
altered by CHX treatment (summarized
in Table
2).
Sequence analysis of the trapped genes.
To identify the
trapped genes, the cellular sequences contained in the chimeric
transcripts expressed in the trap lines were analyzed by 5'-RACE. The
5'-RACE products, ranging from 50 to 500 bp in length (average, 100 bp), were sequenced, and the data were compared to GenBank and
SwissProt databases using the BLASTN or BLASTX algorithm, respectively,
to search for sequence similarities. In 12 cases, identical sequences
were detected in the databases at this stage (Table 2; genes with
accession numbers). For the remaining cases, 3'-RACE with RNA from
TGF-
-treated A549 cells was performed to analyze sequences of the
trapped genes further downstream. The lengths of the 3'-RACE products
ranged from 200 to 2,000 bp (average, 400 bp). No additional identical
sequences were detected in the databases at this stage. The known genes whose upregulation was confirmed by RNA blot hybridization include two
previously described TGF-
-responsive genes, EGF receptor (47) and
1-integrin (19). TGF-
regulation
has not been described for the other genes. The known
TGF-
-responsive genes can be roughly classified into three
categories based on the properties of their products: (i)
growth-associated proteins (EGF receptor, ribosomal protein S15a,
hnRNP-K/tump, hNRP/NAP-1, lipocortin II), (ii) focal adhesion-associated proteins (paxillin,
1-integrin), and (iii) thyroid hormone receptor coactivator (TRAM-1) (Table 2). The insertional events in 10 out of 12 known genes have occurred in the
5'-noncoding region and in the other two cases near the 5' end within
the coding region (data not shown).
 |
DISCUSSION |
In this study, we have attempted to apply a retrovirus-mediated
gene trap strategy to identify genes responsive to TGF-
. In this
first trial, we could identify 15 genes whose transcripts were
upregulated after TGF-
treatment. Two of these genes, the EGF
receptor and
1-integrin genes, have previously been reported to be
upregulated by TGF-
(19, 47), seven others are known genes not previously noticed to be responsive to TGF-
, and the remainder (six genes) are either novel or cloned but poorly
characterized. Although the initial screening by X-Gal staining yielded
6 additional trap lines whose reporter activities were responsive to
TGF-
, we failed to detect the upregulation of the corresponding
endogenous genes in parental A549 cells after TGF-
treatment by RNA
blot hybridization (6 out of 21 lines; 29%). Even among the genes
whose differential expression was confirmed by RNA blot hybridization, the induction of
-Gal activity in trap lines and the induction of
mRNA in A549 cells were not always proportional (compare Fig. 2 and 4;
qualitatively summarized in Table 2). Since most trap lines have
retroviral insertions at or near the 5' ends of target genes, the
reporter gene expression should reflect the upstream promoter activity
but not the effects of internal regulatory elements or mRNA stability
of the target genes. This may be a reason for the discrepancy between
-Gal data and RNA blot data. Nevertheless, the 71% (15 of 21)
success rate would justify further application of the present approach
as a first screening for differentially expressed genes in cultured
cells. Furthermore, we could isolate novel genes at a very high
frequency (9 of 21; 43%), suggesting that our approach can detect a
gene population rarely recognized by the other common methods to
isolate cDNA. Since this method targets chromosomal DNA, the influence
of mRNA abundance on the repertoire of the genes identified is expected
to be minimum. In addition, the selection drug employed in this study
(BLA-S) has several advantages over other commonly used drugs such as G418. BLA-S can rapidly kill many types of cells at relatively low
concentrations (less than 1 µg/ml) even at high cell densities. Thus
low-level expression of the marker gene (bsd) can confer clear-cut resistance to the cells. We could therefore minimize the bias
due to the enrichment of the cells expressing relatively high levels of
marker genes during the initial drug selection step.
One important advantage of this approach is that we obtain trap lines
before isolating trapped genes. Information on the response of the
reporter gene to various stimuli helps to classify the trap lines and
to decide which lines should be further characterized. Trap lines
themselves may also be useful in finding interactions between different
signaling pathways. For instance, a majority of the trap lines tested
in this study (11 of 14) responded to a phorbol ester, PMA (Table 1).
This seems consistent with the recent finding by Zhang et al.
(53) that a Smad3-Smad4 complex can activate a
tetradecanoyl phorbol acetate (another phorbol ester similar to
PMA)-responsive element (TRE) directly or in conjunction with c-Fos and
c-Jun. Thus, it will be interesting to see whether the associated genes
have TRE in their promoters and to examine whether these genes are
indeed regulated directly by these signals. As another example, IFN-
was found to suppress the TGF-
-induced reporter expression in many
trap lines (12 of 14). This is also consistent with the recent finding
by Ulloa et al. (49) that IFN-
induces the expression of
an antagonistic SMAD (Smad7) thereby inhibiting receptor-mediated Smad3
phosphorylation, a triggering event in SMAD-mediated signal
transduction. Thus, studies with a panel of trap lines and various
reagents or stimuli may help in finding novel interactions between
apparently independent signaling pathways.
Another important advantage of this approach is its reliability in
identifying trapped genes. In this experiment, we could obtain 5'-RACE
products from all the trap lines isolated and could eventually isolate
full coding sequences of some of the novel genes by 3'-RACE (Akiyama et
al., unpublished data); 3'-RACE was effective enough to clone a cDNA of
up to 2 kb, which was sufficient for recovering the coding regions of
relatively small genes. For confirmation of their sequences, we also
screened some commercially available phage cDNA libraries (human
placenta and testis) with radiolabeled 3'-RACE products (more than 1.4 kb in length) as probes. In most cases, the frequencies of
hybridization-positive clones were less than 10
5,
indicating low expression of these genes in placenta and testis. Importantly, the cDNA fragments initially isolated by 5'-RACE usually
correspond to the 5'-terminal regions of the trapped genes. This is in
contrast to the other methods designed to detect differential gene
expression, which often target the 3' ends of mRNAs, a region suitable
for gene identification because of the sequence diversity even among
members of the same gene family. Although 5'-noncoding sequences should
serve the same purpose, one drawback at the moment is that the sequence
information for this region is often lacking in the database because of
a technical reason: isolation of this region has been relatively
difficult by the classical procedures for cDNA synthesis. The gene trap
approach is expected to enrich such information and also facilitate the
analysis of the promoter regions of the trapped genes.
The regulation of trapped genes was first screened by X-Gal staining,
then examined quantitatively by
-Gal assay, and finally confirmed by
RNA blot hybridization. The
-Gal assay was sensitive enough to
detect a difference of expression as small as 1.6-fold (Fig. 2),
although the biological significance of such small changes remains to
be clarified. Since the present format of the gene trap approach relies
on the initial drug selection of trap lines, which usually takes
several hours to days, the genes upregulated only transiently after
application of a signal probably escape the screening. The genes
isolated by this approach would therefore represent genes whose
expression is persistently altered, directly or indirectly, by the
signal. We found that in some cases analysis of the effects of CHX by
RNA blot hybridization may clarify this point. For instance, CHX had
little influence on the TGF-
responsiveness of some of the genes
identified in this study (e.g., A4, A83, A126, and A152), suggesting
that the response of these genes did not require de novo protein
synthesis and that therefore the genes may represent the primary
targets for the TGF-
signal. In contrast, CHX seems to cancel the
upregulating effects of TGF-
on some other genes, such as A82 and
A114, suggesting that they may not be the primary targets. In some
other cases (A70, A88, A162, and A164), however, CHX reduced the
amounts of mRNA to levels well below those in the naive A549 cells (no
addition of TGF-
), suggesting that these genes require some
CHX-sensitive component(s) to maintain their basal activity or mRNA
stability. Yet in some other cases (A26, A96, and A161), CHX increased
the amounts of mRNA to levels significantly higher than those in the
TGF-
-treated cells, suggesting the involvement of either
CHX-sensitive negative regulators (which may or may not be specific to
TGF-
signaling) or CHX-induced positive regulators. For the last two
groups of genes, the effects of TGF-
may be masked by the effects of
CHX, and therefore it seems difficult to judge through this method
whether these genes represent the primary targets for the TGF-
signal or not.
We initially expected that counter-selection with GCV may facilitate
the elimination of trap lines with constitutively expressed genes.
Inclusion of counter-selection, however, did not significantly improve
the efficiency of trap line isolation: 13 of 117 trap lines (11%)
after counter-selection versus 8 of 132 trap lines (6.1%) without
counter-selection. A quantitative comparison of levels of reporter gene
expression (Fig. 2) suggests that the counter-selection might have
served to select for trap lines with low background expression but
that, on the other hand, it might have eliminated trap lines with
strongly expressed genes. Moreover, high concentrations of GCV
nonspecifically damage the cells, and this may interfere with the
subsequent X-Gal assay because of an endogenous
-Gal-like activity
(10, 27) induced in damaged cells. Thus, we could not take
full advantage of counter-selection in this study. The
counter-selection may, however, be useful in cases where genes are
regulated in a more stringent fashion.
Among the nine genes confirmed to respond to TGF-
in this study,
five genes (the EGF receptor, ribosomal protein S15a, hnRNP-K/tump, hNRP/NAP-1, and lipocortin II genes) can be classified as growth associated. In fact, these genes are known to be upregulated in growing
and/or malignant cells (4, 6, 8, 22, 31, 44). It has been
known for some time that TGF-
induces EGF receptor expression
(47). Our finding indicates that induction of
growth-associated genes by TGF-
is not a rare event. Importantly, other growth factors, such as EGF, PDGF, and IGF-1, failed to induce
these growth-associated genes. This may explain why TGF-
exhibits a
paradoxical growth-promoting activity when present with other growth
factors in certain types of cells (38). On the other hand,
preliminary experiments indicated that the overexpression of the A83
gene suppressed the growth of A549 cells (Matsuo et al., unpublished
data). Thus, these novel genes may play some roles in TGF-
-induced
growth inhibition. The two focal adhesion-associated proteins detected
in this study (
1-integrin and paxillin) may also contribute to the
growth-inhibitory effects (14, 48). Although the extent of
induction was small, TRAM-1 was found to respond to TGF-
. This might
suggest a possible molecular basis for the cooperative effects between
thyroid hormone and TGF-
observed in certain systems (28,
45).
In conclusion, we could detect, by using retrovirus-mediated gene trap
screening, a series of known and novel genes persistently upregulated
by TGF-
. We could also examine the patterns of their responses to
various stimuli using the trap lines. Based on these results, we
conclude that this approach has several unique advantages over other
methods and should provide a useful tool to detect and isolate genes
that are responsive to various external stimuli in cultured cells.
Further characterization of the novel genes isolated in this study may
yield important insights into the mechanism of action of TGF-
.
 |
ACKNOWLEDGMENTS |
We thank P. Soriano for pROSA
-geo, A. Takeshita for TRAM-1
cDNA, T. Noguchi for pyruvate kinase cDNA, Toyobo Co. Ltd. for providing some materials, Mariko Sasa, Yasuko Ono, and Takashi Kawai
for technical assistance, and Aki Miyazaki for secretarial assistance.
This work was supported by research grants from the Ministry of
Education, Science, Sports, and Culture of Japan and from Sankyo Co., Ltd.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Oncology, Kyoto University Graduate School of Medicine,
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan. Phone:
81-75-751-4150. Fax: 81-75-751-4159. E-mail:
mnoda{at}virus.kyoto-u.ac.jp.
 |
REFERENCES |
| 1.
|
Akiyama, N.,
D. Alexander,
Y. Aoki, and M. Noda.
1996.
Characterization of mutations induced by 300 and 320 nm UV radiation in a rat fibroblast cell line.
Mutat. Res.
372:119-131[Medline].
|
| 2.
|
Andreu, T.,
T. Beckers,
E. Thoenes,
P. Hilgard, and H. von Melchner.
1998.
Gene trapping identifies inhibitors of oncogenic transformation.
J. Biol. Chem.
273:13848-13854[Abstract/Free Full Text].
|
| 3.
|
Benditt, J. O.,
C. Mayer,
H. Fasold,
F. C. Barnard, and N. Riedel.
1989.
Interaction of a nuclear location signal with isolated nuclear envelopes and identification of signal-binding proteins by photoaffinity labeling.
Proc. Natl. Acad. Sci. USA
86:9327-9331[Abstract/Free Full Text].
|
| 4.
|
Bonham-Smith, P. C.,
T. L. Oancia, and M. M. Moloney.
1992.
Cytoplasmic ribosomal protein S15a from Brassica napus: molecular cloning and developmental expression in mitotically active tissues.
Plant Mol. Biol.
18:909-919[CrossRef][Medline].
|
| 5.
|
Bortolin, M. L., and T. Kiss.
1998.
Human U19 intron-encoded snoRNA is processed from a long primary transcript that possesses little potential for protein coding.
RNA
4:445-454[Abstract].
|
| 6.
|
Cole, S. P.,
M. J. Pinkoski,
G. Bhardwaj, and R. G. Deeley.
1992.
Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.
Br. J. Cancer
65:498-502[Medline].
|
| 7.
|
Datto, M. B.,
Y. Li,
J. F. Panus,
D. J. Howe,
Y. Xiong, and X. F. Wang.
1995.
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
Proc. Natl. Acad. Sci. USA
92:5545-5549[Abstract/Free Full Text].
|
| 8.
|
Dejgaard, K.,
H. Leffers,
H. H. Rasmussen,
P. Madsen,
T. A. Kruse,
B. Gesser,
H. Nielsen, and J. E. Celis.
1994.
Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing.
J. Mol. Biol.
236:33-48[CrossRef][Medline].
|
| 9.
|
Diatchenko, L.,
Y.-F. C. Lau,
A. P. Campbell,
A. Chenchik,
F. Moqadam,
B. Huang,
S. Lukyanov,
K. Lukyanov,
N. Gurskaya,
E. D. Sverdlov, and P. D. Siebert.
1996.
Suppression subtractive hybridization: a method for generating differentially regulated or tissue specific cDNA probes and libraries.
Proc. Natl. Acad. Sci. USA
93:6025-6030[Abstract/Free Full Text].
|
| 10.
|
Dimri, G. P.,
X. Lee,
G. M. Basile,
M. Acosta,
G. Scott,
C. Roskelley,
E. E. Medrano,
M. Linskens,
I. Rubel,
O. Pereira-Smith,
M. Peacocke, and J. Campisi.
1995.
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Proc. Natl. Acad. Sci. USA
92:9363-9367[Abstract/Free Full Text].
|
| 11.
|
Forrester, L. M.,
A. Nagy,
M. Sam,
A. Watt,
L. Stevenson,
A. Bernstein,
A. L. Joyner, and W. Wurst.
1996.
An induction gene trap screen in embryonic stem cells: identification of genes that respond to retinoic acid in vitro.
Proc. Natl. Acad. Sci. USA
93:1677-1682[Abstract/Free Full Text].
|
| 12.
|
Friedrich, G., and P. Soriano.
1991.
Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice.
Genes Dev.
5:1513-1523[Abstract/Free Full Text].
|
| 13.
|
Fredrich, G., and P. Soriano.
1993.
Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells.
Methods Enzymol.
225:681-701[Medline].
|
| 14.
|
Giancotti, F. G., and E. Ruoslahti.
1990.
Elevated levels of the 5 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.
Cell
60:849-859[CrossRef][Medline].
|
| 15.
|
Giard, D. J.,
S. A. Aaronson,
G. J. Todaro,
P. Arnstein,
J. H. Kersey,
H. Dosik, and W. P. Parks.
1973.
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.
J. Natl. Cancer Inst.
51:1417-1423.
|
| 16.
|
Gossler, A., and J. Zachgo.
1993.
Gene and enhancer trap screens in ES cell chimeras, p. 181-277.
In
A. L. Joyner (ed.), Gene targeting: a practical approach. Oxford University Press, New York, N.Y.
|
| 17.
|
Hahn, S. A.,
M. Schutte,
A. T. Hoque,
C. A. Moskaluk,
L. T. de Costa,
E. Rosenblum,
C. L. Weinstein,
A. Fischer,
C. J. Xeo,
R. H. Hruban, and S. E. Kern.
1996.
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
Science
271:350-353[Abstract].
|
| 18.
|
Hannon, G. J., and D. Beach.
1995.
P15INK4B is a potential effecter of TGF- -induced cell cycle arrest.
Nature
371:257-261.
|
| 19.
|
Heino, J.,
R. A. Ignotz,
M. E. Hemler,
C. Crouse, and J. Massague.
1989.
Regulation of cell adhesion receptors by transforming growth factor- . Concomitant regulation of integrins that share a common beta 1 subunit.
J. Biol. Chem.
264:380-388[Abstract/Free Full Text].
|
| 20.
|
Heiss, N. S.,
G. Gloeckner,
D. Bächner,
P. Kioschis,
S. M. Klauck,
B. Hinzmann,
A. Rosenthal,
G. E. Herman, and A. Pouska.
1997.
Genomic structure of a novel LIM domain gene (ZNF185) in Xq28 and comparisons with the orthologous murine transcript.
Genomics
43:329-338[CrossRef][Medline].
|
| 21.
|
Heldin, C. H.,
K. Miyazono, and P. ten Dijke.
1997.
TGF- signaling from cell membrane to nucleus through SMAD proteins.
Nature
390:465-471[CrossRef][Medline].
|
| 22.
|
Huang, K. S.,
B. P. Wallner,
R. J. Mattaliano,
R. Tizard,
C. Burne,
A. Frey,
C. Hession,
P. McGray,
L. K. Sinclair, and E. P. Chow.
1986.
Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase.
Cell
46:191-199[CrossRef][Medline].
|
| 23.
|
Hubank, M., and S. G. Schatz.
1994.
Identifying differences in mRNA expression by representational difference analysis of cDNA.
Nucleic Acids Res.
22:5640-5648[Abstract/Free Full Text].
|
| 24.
|
Kamakura, T.,
K. Kobayashi,
T. Tanaka,
I. Yamaguchi, and E. Toyoshige.
1987.
Cloning and expression of a new structural gene for blasticidin S deaminase, a nucleoside aminohydrolase.
Agric. Biol. Chem.
51:3165-3168.
|
| 25.
|
Kato, H.,
T. Fukuda,
C. Parkinson,
P. McPhie, and S. Y. Cheng.
1989.
Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase.
Proc. Natl. Acad. Sci. USA
86:7861-7865[Abstract/Free Full Text].
|
| 26.
|
Kerr, W. G.,
M. Heller, and L. A. Herzenberg.
1996.
Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains.
Proc. Natl. Acad. Sci. USA
93:3947-3952[Abstract/Free Full Text].
|
| 27.
|
Kuo, C. H., and W. W. Wells.
1978.
-Galactosidase from rat mammary gland. Its purification, properties, and role in the biosynthesis of 6 -O-D-galactopyranosyl myo-inositol.
J. Biol. Chem.
253:3550-3556[Free Full Text].
|
| 28.
|
LaKatos, P., and P. H. Stern.
1992.
Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones.
Calcif. Tissue Int.
50:123-128[CrossRef][Medline].
|
| 29.
|
Lee, N. H.,
K. G. Weinstock,
E. F. Kirkness,
J. A. Earle-Hughes,
R. A. Fuldner,
S. Marmaros,
A. Glodek,
J. D. Gocayne,
M. D. Adams,
A. R. Kerlavage,
C. M. Fraser, and J. C. Venter.
1995.
Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment.
Proc. Natl. Acad. Sci. USA
92:8303-8307[Abstract/Free Full Text].
|
| 30.
|
Liang, P., and A. B. Pardee.
1992.
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
Science
257:967-971[Abstract/Free Full Text].
|
| 31.
|
Libermann, T. A.,
H. R. Nusbaum,
N. Razon,
R. Kris,
I. Lax,
H. Soreq,
N. Whittle,
M. D. Waterfield,
A. Ullrick, and J. Schlessinger.
1985.
Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin.
Nature
313:144-147[CrossRef][Medline].
|
| 32.
|
Markowitz, S. D., and A. B. Roberts.
1996.
Tumor suppressor activity of the TGF- pathway in human cancers.
Cytokine Growth Factor Rev.
7:93-102[CrossRef][Medline].
|
| 33.
|
Markowitz, D.,
S. Goff, and A. Bank.
1988.
Construction and use of a safe and efficient amphotropic packaging call line.
Virology
167:400-406[Medline].
|
| 34.
|
Massague, J.
1998.
TGF- signal transduction.
Annu. Rev. Biochem.
67:753-791[CrossRef][Medline].
|
| 35.
|
Noguchi, T.,
H. Inoue, and T. Tanaka.
1986.
The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing.
J. Biol. Chem.
261:13807-13812[Abstract/Free Full Text].
|
| 36.
|
Parry, H. D., and L. Alphey.
1987.
The utilization of cloned DNAs to study gene organization and expression, p. 177-178.
In
D. M. Glover, and B. D. Hames (ed.), DNA cloning 1, core techniques, 2nd ed. IRL Press, Oxford, United Kingdom.
|
| 37.
|
Reynisdottir, I.,
K. Polyak,
A. Iavarone, and J. Massague.
1995.
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF- .
Genes Dev.
9:1831-1845[Abstract/Free Full Text].
|
| 38.
|
Roberts, A. B.,
M. A. Anzano,
L. M. Wakefield,
N. S. Roche,
F. D. Stern, and M. B. Sporn.
1985.
Type transforming growth factor: a bifunctional regulator of cellular growth.
Proc. Natl. Acad. Sci. USA
82:119-123[Abstract/Free Full Text].
|
| 39.
|
Russ, A. P.,
C. Friedel,
K. Ballas,
U. Kalina,
D. Zahn,
K. Strebhardt, and H. von Melchner.
1996.
Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination.
Proc. Natl. Acad. Sci. USA
93:15279-15284[Abstract/Free Full Text].
|
| 40.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1987.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 41.
|
Sanes, J. R.,
J. L. Rubenstein, and J. F. Nicolas.
1986.
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J.
5:3133-3142[Medline].
|
| 42.
|
Schena, M.,
K. Shalon,
R. W. Davis, and P. O. Brown.
1995.
Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
Science
270:467-470[Abstract/Free Full Text].
|
| 43.
|
Scheridin, U.,
K. Rhodes, and M. Breindl.
1990.
Transcriptionally active genome regions are preferred targets for retrovirus integration.
J. Virol.
64:907-912[Abstract/Free Full Text].
|
| 44.
|
Simon, H. U.,
G. B. Mills,
M. Kozlowski,
D. Hogg,
D. Branch,
Y. Ishimi, and K. A. Siminovitch.
1994.
Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-1-related gene product involved in the induction of cell proliferation.
Biochem. J.
297:389-397.
|
| 45.
|
Sumitani, S.,
S. Kasayama, and B. Sato.
1994.
Tyroid hormone inhibits androgen-enhanced DNA synthesis in Shionogi carcinoma 115 cells without affecting autocrine growth factor mRNA expression.
J. Steroid Biochem. Mol. Biol.
50:5-11[CrossRef][Medline].
|
| 46.
|
Takeshita, A.,
G. R. Cardona,
N. Koibuchi,
C. S. Suen, and W. W. Chin.
1997.
TRAM-1 a novel 160 kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.
J. Biol. Chem.
272:27629-27634[Abstract/Free Full Text].
|
| 47.
|
Thompson, K. L.,
R. Assoian,
M. R. Rosner, and C. J. Marshall.
1988.
Transforming growth factor- increases transcription of the genes encoding the epidermal growth factor receptor and fibronectin in normal rat kidney fibroblasts.
J. Biol. Chem.
263:19519-19524[Abstract/Free Full Text].
|
| 48.
|
Tong, X., and P. M. Howley.
1997.
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.
Proc. Natl. Acad. Sci. USA
94:4412-4417[Abstract/Free Full Text].
|
| 49.
|
Ulloa, L.,
J. Doody, and J. Massague.
1999.
Inhibition of transforming growth factor- /SMAD signalling by interferon- /STAT pathway.
Nature
397:710-713[CrossRef][Medline].
|
| 50.
|
Vasmatzis, G.,
M. Essand,
U. Brinkmann,
B. Lee, and I. Pastan.
1998.
Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis.
Proc. Natl. Acad. Sci. USA
95:300-304[Abstract/Free Full Text].
|
| 51.
|
Velculescu, V. E.,
L. Zhang,
B. Vogelstein, and K. W. Kizler.
1995.
Serial analysis of gene expression.
Science
270:484-487[Abstract/Free Full Text].
|
| 52.
|
Zhang, Y., and R. Derynck.
1999.
Regulation of Smad signaling by protein associations and signaling crosstalk.
Trends Cell Biol.
9:274-279[CrossRef][Medline].
|
| 53.
|
Zhang, Y.,
X.-H. Feng, and R. Derynck.
1998.
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF- -induced transcription.
Nature
394:909-913[CrossRef][Medline].
|
Molecular and Cellular Biology, May 2000, p. 3266-3273, Vol. 20, No. 9
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Matsuo, Y., Masutani, H., Son, A., Kizaka-Kondoh, S., Yodoi, J.
(2009). Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses. Mol. Biol. Cell
20: 4552-4562
[Abstract]
[Full Text]
-
Gerhardinger, C., Dagher, Z., Sebastiani, P., Park, Y. S., Lorenzi, M.
(2009). The Transforming Growth Factor-{beta} Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy. Diabetes
58: 1659-1667
[Abstract]
[Full Text]
-
Brown, M. C., Turner, C. E.
(2004). Paxillin: Adapting to Change. Physiol. Rev.
84: 1315-1339
[Abstract]
[Full Text]
-
Smith, C. L., O'Malley, B. W.
(2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocr. Rev.
25: 45-71
[Abstract]
[Full Text]
-
Harada, H., Hiraoka, M., Kizaka-Kondoh, S.
(2002). Antitumor Effect of TAT-Oxygen-dependent Degradation-Caspase-3 Fusion Protein Specifically Stabilized and Activated in Hypoxic Tumor Cells. Cancer Res.
62: 2013-2018
[Abstract]
[Full Text]
-
Matsuo, Y., Akiyama, N., Nakamura, H., Yodoi, J., Noda, M., Kizaka-Kondoh, S.
(2001). Identification of a Novel Thioredoxin-related Transmembrane Protein. J. Biol. Chem.
276: 10032-10038
[Abstract]
[Full Text]